Correlation Between Travere Therapeutics and Atreca
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Atreca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Atreca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Atreca Inc, you can compare the effects of market volatilities on Travere Therapeutics and Atreca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Atreca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Atreca.
Diversification Opportunities for Travere Therapeutics and Atreca
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Travere and Atreca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Atreca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atreca Inc and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Atreca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atreca Inc has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Atreca go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Atreca
If you would invest 1,715 in Travere Therapeutics on December 22, 2024 and sell it today you would earn a total of 338.00 from holding Travere Therapeutics or generate 19.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Travere Therapeutics vs. Atreca Inc
Performance |
Timeline |
Travere Therapeutics |
Atreca Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Travere Therapeutics and Atreca Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Travere Therapeutics and Atreca
The main advantage of trading using opposite Travere Therapeutics and Atreca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Atreca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will offset losses from the drop in Atreca's long position.Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |